{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T07:32:42Z","timestamp":1790321562697,"version":"4.1.0"},"reference-count":282,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"DOI":"10.3389\/fnins.2016.00375","type":"journal-article","created":{"date-parts":[[2016,8,22]],"date-time":"2016-08-22T03:18:56Z","timestamp":1471835936000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":70,"title":["Key Targets for Multi-Target Ligands Designed to Combat Neurodegeneration"],"prefix":"10.3389","volume":"10","author":[{"given":"Rona R.","family":"Ramsay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Majekova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milagros","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Valoti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2016,8,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s12035-012-8352-z","article-title":"Overlapped metabolic and therapeutic links between Alzheimer and diabetes","volume":"47","author":"Ahmad","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s12272-013-0036-3","article-title":"A review on cholinesterase inhibitors for Alzheimer's disease","volume":"36","author":"Anand","year":"2013","journal-title":"Arch. Pharmac. Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1212\/WNL.0000000000001613","article-title":"A slowly progressive mitochondrial encephalomyopathy widens the spectrum of AIFM1 disorders","volume":"84","author":"Ardissone","year":"2015","journal-title":"Neurology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/0197-0186(92)90189-X","article-title":"Changes in acetylcholinesterase and butyrylcholinesterase in alzheimers-disease resemble embryonic-development - a study of molecular-forms","volume":"21","author":"Arendt","year":"1992","journal-title":"Neurochem. Int."},{"key":"B5","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1083\/jcb.201401070","article-title":"Mitophagy of damaged mitochondria occurs locally in distal neuronal axons and requires PINK1 and Parkin","volume":"206","author":"Ashrafi","year":"2014","journal-title":"J. Cell Biol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1023\/A:1006982732681","article-title":"Metabolism of monoamine oxidase inhibitors","volume":"19","author":"Baker","year":"1999","journal-title":"Cell. Mol. Neurobiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2478\/intox-2014-0005","article-title":"Antioxidant action of SMe1EC2, the low-basicity derivative of the pyridoindole stobadine, in cell free chemical models and at cellular level","volume":"7","author":"Balcerczyk","year":"2014","journal-title":"Interdiscipl. Toxicol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/nsmb.1553","article-title":"MIA40 is an oxidoreductase that catalyzes oxidative protein folding in mitochondria","volume":"16","author":"Banci","year":"2009","journal-title":"Nat. Struct. Mol. Biol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0006-2952(02)01514-9","article-title":"\u03b2-amyloid aggregation induced by human acetylcholinesterase: inhibition studies","volume":"65","author":"Bartolini","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"B10","first-page":"821","article-title":"MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease","volume":"46","author":"Bartzokis","year":"2000","journal-title":"Cell. Mol. Biol (Noisy-le-grand)."},{"key":"B11","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ejmech.2013.12.028","article-title":"Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modeling and ADMET of novel donepezil-indolyl hybrids as multipotent cholinesterase\/monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease","volume":"75","author":"Bautista-Aguilera","year":"2014a","journal-title":"Eur. J. Med. Chem."},{"key":"B12","doi-asserted-by":"publisher","first-page":"10455","DOI":"10.1021\/jm501501a","article-title":"N-Methyl-N-((1-methyl-5-(3-(1-(2-methylbenzyl)piperidin-4yl).propoxy).-1H- indol-2-yl).methyl)prop-2-yn-1-amine, a New Cholinesterase and Monoamine Oxidase Dual","volume":"57","author":"Bautista-Aguilera","year":"2014b","journal-title":"J. Med. Chem."},{"key":"B13","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.brainres.2013.09.037","article-title":"Effects of the neurotoxin MPTP and pargyline protection on extracellular energy metabolites and dopamine levels in the striatum of freely moving rats","volume":"1538","author":"Bazzu","year":"2013","journal-title":"Brain Res."},{"key":"B14","doi-asserted-by":"crossref","first-page":"235","DOI":"10.18388\/abp.2010_2400","article-title":"Antioxidant properties of PF9601N, a novel MAO-B inhibitor: assessment of its ability to interact with reactive nitrogen species","volume":"57","author":"Bellik","year":"2010","journal-title":"Acta. Biochim. Pol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.2174\/0929867322666150114163051","article-title":"A direct interaction between mitochondrial proteins and amyloid-beta peptide and its significance for the progression and treatment of Alzheimer's Disease","volume":"22","author":"Benek","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"B16","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.ymgme.2011.09.020","article-title":"Early prenatal ventriculomegaly due to an AIFM1 mutation identified by linkage analysis and whole exome sequencing","volume":"104","author":"Berger","year":"2011","journal-title":"Mol. Genet. Metabolism"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1161\/CIRCRESAHA.115.306557","article-title":"From ATP to PTP and Back: a dual function for the Mitochondrial ATP Synthase","volume":"116","author":"Bernardi","year":"2015","journal-title":"Circ. Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nsb732","article-title":"Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders","volume":"9","author":"Binda","year":"2002","journal-title":"Nat. Struct. Biol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"6827","DOI":"10.1021\/ja101557k","article-title":"Biochemical, Structural, and Biological Evaluation of Tranylcypromine derivatives as inhibitors of Histone Demethylases LSD1 and LSD2","volume":"132","author":"Binda","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"B20","doi-asserted-by":"publisher","first-page":"5848","DOI":"10.1021\/jm070677y","article-title":"Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: Safinamide and coumarin analogs","volume":"50","author":"Binda","year":"2007","journal-title":"J. Med. Chem."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.bbagen.2013.10.017","article-title":"Modelling biochemical features of mitochondrial neuropathology","volume":"1840","author":"Bird","year":"2014","journal-title":"Biochim. Biophys. Acta."},{"key":"B22","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/cns.12271","article-title":"Neuroprotective effects of the MAO-B inhibitor, PF9601N, in an in vivo model of excitotoxicity","volume":"20","author":"Bolea","year":"2014","journal-title":"CNS Neurosci. Ther."},{"key":"B23","doi-asserted-by":"publisher","first-page":"797","DOI":"10.2174\/15672050113109990151","article-title":"Multipotent, Permeable Drug ASS234 Inhibits A beta Aggregation, possesses antioxidant properties and protects from a beta-induced Apoptosis in vitro","volume":"10","author":"Bolea","year":"2013","journal-title":"Curr. Alzheimer Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"8251","DOI":"10.1021\/jm200853t","article-title":"Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy).-1-methyl-1H-indol-2-yl).methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase\/monoamine oxidase inhibitors for the treatment of Alzheimer's Disease","volume":"54","author":"Bolea","year":"2011","journal-title":"J. Med. Chem."},{"key":"B25","doi-asserted-by":"publisher","first-page":"6446","DOI":"10.1021\/jm701225u","article-title":"Multi-target-directed drug design strategy: from a dual binding site acetylcholinesterase inhibitor to a trifunctional compound against Alzheimer's disease","volume":"50","author":"Bolognesi","year":"2007","journal-title":"J. Med. Chem."},{"key":"B26","doi-asserted-by":"publisher","first-page":"36849","DOI":"10.1074\/jbc.M110.169482","article-title":"Potentiation of ligand binding through cooperative effects in monoamine oxidase B","volume":"285","author":"Bonivento","year":"2010","journal-title":"J. Biol. Chem."},{"key":"B27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2174\/1567205011310010004","article-title":"Is amyloid binding alcohol dehydrogenase a drug target for treating Alzheimer's disease?","volume":"10","author":"Borger","year":"2013","journal-title":"Curr. Alzheimer Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/b978-0-12-386467-3.00002-9","article-title":"Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence","volume":"100","author":"Bortolato","year":"2011","journal-title":"Int. Rev. Neurobiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"176","DOI":"10.15252\/emmm.201505894","article-title":"Defective PITRM1 mitochondrial peptidase is associated with A\u03b2 amyloidotic neurodegeneration","volume":"8","author":"Brunetti","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1126\/science.8211186","article-title":"Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase-A","volume":"262","author":"Brunner","year":"1993","journal-title":"Science"},{"key":"B31","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1042\/BJ20140772","article-title":"Redox proteomics analysis to decipher the neurobiology of Alzheimer-like neurodegeneration: overlaps in Down's syndrome and Alzheimer's disease brain","volume":"463","author":"Butterfield","year":"2014","journal-title":"Biochem. J."},{"key":"B32","doi-asserted-by":"publisher","first-page":"3588","DOI":"10.1021\/jm8001313","article-title":"Novel donepezil-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation","volume":"51","author":"Camps","year":"2008","journal-title":"J. Med. Chem."},{"key":"B33","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1517\/13543776.2014.982535","article-title":"Novel monoamine oxidase inhibitors: a patent review (2012-2014)","volume":"25","author":"Carradori","year":"2015","journal-title":"Expert Opin. Ther. Pat."},{"key":"B34","doi-asserted-by":"publisher","first-page":"29723","DOI":"10.1074\/jbc.M805356200","article-title":"Mitochondrial biogenesis, switching the sorting pathway of the intermembrane space receptor Mia40","volume":"283","author":"Chacinska","year":"2008","journal-title":"J. Biol. Chem."},{"key":"B35","doi-asserted-by":"publisher","first-page":"39645","DOI":"10.1074\/jbc.M405550200","article-title":"A spontaneous point mutation produces monoamine oxidase A\/B knock-out mice with greatly elevated monoamines and anxiety-like behavior","volume":"279","author":"Chen","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B36","doi-asserted-by":"publisher","first-page":"4061","DOI":"10.1038\/sj.emboj.7601276","article-title":"Dissociating the dual roles of apoptosis-inducing factor in maintaining mitochondrial structure and apoptosis","volume":"25","author":"Cheung","year":"2006","journal-title":"EMBO J."},{"key":"B37","doi-asserted-by":"publisher","first-page":"10282","DOI":"10.1021\/jm300871x","article-title":"Structures of Human acetylcholinesterase in complex with pharmacologically important ligands","volume":"55","author":"Cheung","year":"2012","journal-title":"J. Med. Chem."},{"key":"B38","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.expneurol.2006.07.021","article-title":"Activation of 5-HT4 receptors inhibits secretion of beta-amyloid peptides and increases neuronal survival","volume":"203","author":"Cho","year":"2007","journal-title":"Exp. Neurol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"5622","DOI":"10.1074\/jbc.M709147200","article-title":"Redox-dependent changes in molecular properties of mitochondrial apoptosis-inducing factor","volume":"283","author":"Churbanova","year":"2008","journal-title":"J. Biol. Chem."},{"key":"B40","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1021\/cn300095t","article-title":"5-HT4 receptors constitutively promote the non-amyloidogenic pathway of APP cleavage and interact with ADAM10","volume":"4","author":"Cochet","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.cell.2013.08.032","article-title":"Mitochondrial cristae shape determines respiratory chain supercomplexes assembly and respiratory efficiency","volume":"155","author":"Cogliati","year":"2013","journal-title":"Cell"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1091\/mbc.E08-02-0227","article-title":"Ubiquitin-proteasome-dependent degradation of a mitofusin, a critical regulator of mitochondrial fusion","volume":"19","author":"Cohen","year":"2008","journal-title":"Mol. Biol. Cell."},{"issue":"138","key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2010.00138","article-title":"Mitochondrial preconditioning: a potential neuroprotective strategy","volume":"2","author":"Correia","year":"2010a","journal-title":"Front. Aging. Neurosci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.exger.2012.07.006","article-title":"Alzheimer disease as a vascular disorder: where do mitochondria fit?","volume":"47","author":"Correia","year":"2012a","journal-title":"Exp. Gerontol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.brainres.2011.12.063","article-title":"Insulin signaling, glucose metabolism and mitochondria: major players in Alzheimer's disease and diabetes interrelation","volume":"1441","author":"Correia","year":"2012c","journal-title":"Brain Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"S475","DOI":"10.3233\/JAD-2010-100669","article-title":"Mitochondria: the missing link between preconditioning and neuroprotection","volume":"20","author":"Correia","year":"2010b","journal-title":"J. Alzheimers. Dis."},{"key":"B47","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/978-1-4614-0653-2_16","article-title":"Mitochondrial importance in Alzheimer's, Huntington's and Parkinson's diseases","volume":"724","author":"Correia","year":"2012b","journal-title":"Adv. Exp. Med. Biol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20121898","article-title":"The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration","volume":"15","author":"Costanzo","year":"2013","journal-title":"Biochem. J."},{"key":"B49","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.tips.2005.02.007","article-title":"The efficiency of multi-target drugs: the network approach might help drug design","volume":"26","author":"Csermely","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/NEN.0b013e31823cc7a6","article-title":"Butyrylcholinesterase is associated with beta-amyloid plaques in the Transgenic APP(SWE)\/PSEN1dE9 Mouse Model of Alzheimer Disease","volume":"71","author":"Darvesh","year":"2012","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"12684","DOI":"10.1073\/pnas.0505975102","article-title":"Three-dimensional structure of human monoamine oxidase A (MAO A).: relation to the structures of rat MAO A and human MAO B","volume":"102","author":"De Colibus","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1177\/193229680800200619","article-title":"Alzheimer's disease is type 3 diabetes - evidence reviewed","volume":"2","author":"de la Monte","year":"2008","journal-title":"J. Diabetes Sci. Technol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/79936","article-title":"Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy","volume":"26","author":"Delettre","year":"2000","journal-title":"Nat. Genet."},{"key":"B54","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ejphar.2009.04.019","article-title":"DP7, a novel dihydropyridine multidrug resistance reverter, shows only weak inhibitory activity on human CYP3A enzyme(s)","volume":"614","author":"D'Elia","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/ejhg.2015.141","article-title":"A novel AIFM1 mutation expands the phenotype to an infantile motor neuron disease","volume":"24","author":"Diodato","year":"2015","journal-title":"Eur. J. Hum. Genet."},{"key":"B56","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.tips.2012.05.007","article-title":"The neurobiology of sirtuins and their role in neurodegeneration","volume":"33","author":"Donmez","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1046\/j.1471-4159.2003.01927.x","article-title":"Cytochrome P450-dependent metabolism of l-deprenyl in monkey (Cercopithecus aethiops) and C57BL\/6 mouse brain microsomal preparations","volume":"86","author":"Dragoni","year":"2003a","journal-title":"J. Neurochem."},{"key":"B58","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1080\/0049825021000048827","article-title":"l-Deprenyl metabolism by the cytochrome P450 system in monkey (Cercopithecus aethiops) liver microsomes","volume":"33","author":"Dragoni","year":"2003b","journal-title":"Xenobiotica"},{"key":"B59","doi-asserted-by":"publisher","first-page":"473","DOI":"10.18433\/J37P4J","article-title":"CYP-dependent metabolism of PF9601N, a new monoamine oxidase-B inhibitor, by C57BL\/6 mouse and human liver microsomes","volume":"10","author":"Dragoni","year":"2007","journal-title":"J. Pharm. Pharm. Sci."},{"key":"B60","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s12035-012-8271-z","article-title":"Mitochondrial Dysfunction-A Pharmacological Target in Alzheimer's Disease","volume":"46","author":"Eckert","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.ceb.2004.09.011","article-title":"Death by design: apoptosis, necrosis and autophagy","volume":"16","author":"Edinger","year":"2004","journal-title":"Curr. Opin. Cell. Biol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.abb.2007.05.006","article-title":"Structural insights into the mechanism of amine oxidation by monoamine oxidases A and B","volume":"464","author":"Edmondson","year":"2007","journal-title":"Arch. Biochem. Biophys."},{"key":"B63","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A New and Rapid Colorimetric Determination of Acetylcholinesterase Activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.bbapap.2014.03.006","article-title":"Kinetic and structural analysis of the irreversible inhibition of human monoamine oxidases by ASS234, a multi-target compound designed for use in Alzheimer's disease","volume":"1844","author":"Esteban","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"B65","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/S0003-2697(02)00506-7","article-title":"Molar absorption coefficients for the reduced Ellman reagent: reassessment","volume":"312","author":"Eyer","year":"2003","journal-title":"Anal. Biochem."},{"key":"B66","doi-asserted-by":"publisher","first-page":"5561","DOI":"10.1021\/acs.jmedchem.5b00599","article-title":"Structure-based design and optimization of multitarget-Directed 2H-Chromen-2-one derivatives as potent inhibitors of Monoamine Oxidase B and Cholinesterases","volume":"58","author":"Farina","year":"2015","journal-title":"J. Med. Chem."},{"key":"B67","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.tips.2011.08.005","article-title":"Cytochrome P450 enzymes in the brain: emerging evidence of biological significance","volume":"32","author":"Ferguson","year":"2011","journal-title":"Trends Pharmacol. Sci."},{"key":"B68","doi-asserted-by":"publisher","first-page":"4204","DOI":"10.1021\/bi500343r","article-title":"Structural insights into the coenzyme mediated monomer-dimer transition of the pro-apoptotic apoptosis inducing factor","volume":"53","author":"Ferreira","year":"2014","journal-title":"Biochemistry"},{"key":"B69","doi-asserted-by":"publisher","first-page":"5198","DOI":"10.1016\/j.bmc.2007.05.021","article-title":"Human and rat monoamine oxidase-A are differentially inhibited by (S).-4-alkylthioamphetamine derivatives: insights from molecular modeling studies","volume":"15","author":"Fierro","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"B70","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.pharmthera.2014.02.010","article-title":"Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: focus on modulation of CNS monoamine neurotransmitter release","volume":"143","author":"Finberg","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"B71","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1091\/mbc.E12-12-0862","article-title":"Protein import and oxidative folding in the mitochondrial intermembrane space of intact mammalian cells","volume":"24","author":"Fischer","year":"2013","journal-title":"Mol. Biol. Cell."},{"key":"B72","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fnsys.2016.00029","article-title":"Altered Mitochondrial Dynamics and TBI Pathophysiology","volume":"30","author":"Fischer","year":"2016","journal-title":"Front. Syst. Neurosci."},{"key":"B73","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/jlcr.3247","article-title":"Monoamine oxidase: radiotracer chemistry and human studies","volume":"58","author":"Fowler","year":"2015","journal-title":"J. Label. Compd. Radiopharm."},{"key":"B74","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.cell.2006.06.025","article-title":"OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion","volume":"126","author":"Frezza","year":"2006","journal-title":"Cell"},{"key":"B75","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1601-183X.2012.00868.x","article-title":"MAOA genotype, social exclusion and aggression: an experimental test of a gene-environment interaction","volume":"12","author":"Gallardo-Pujol","year":"2013","journal-title":"Genes Brain Behav."},{"key":"B76","doi-asserted-by":"publisher","first-page":"G632","DOI":"10.1152\/ajpgi.00182.2014","article-title":"Decreasing mitochondrial fission alleviates hepatic steatosis in a murine model of nonalcoholic fatty liver disease","volume":"307","author":"Galloway","year":"2014","journal-title":"Am. J. Physiol. Gastrointest. Liver. Physiol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1016\/j.freeradbiomed.2012.09.035","article-title":"Mitochondrial morphology-emerging role in bioenergetics","volume":"53","author":"Galloway","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"B78","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/ana.24396","article-title":"Traumatic brain injury in later life increases risk for Parkinson Disease","volume":"77","author":"Gardner","year":"2015","journal-title":"Ann. Neurol."},{"issue":"48","key":"B79","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2012.00048","article-title":"Cause or effect: misregulation of microRNA pathways in neurodegeneration","volume":"6","author":"Gascon","year":"2012","journal-title":"Front Neurosci."},{"key":"B80","first-page":"574","article-title":"Effect of the new pyridoindole antioxidant SMe1EC2 on functional deficits and oedema formation in rat hippocampus exposed to ischaemia in vitro","volume":"30","author":"G\u00e1sp\u00e1rov\u00e1","year":"2009","journal-title":"Neuro Endocrinol. Lett."},{"key":"B81","doi-asserted-by":"publisher","first-page":"122","DOI":"10.2478\/v10102-010-0051-x","article-title":"Oxidative stress induced by the Fe2+\/ascorbic acid system or model ischemia in vitro: effect of carvedilol and pyridoindole antioxidant SMe1EC2 in young and adult rat brain tissue","volume":"3","author":"G\u00e1sp\u00e1rov\u00e1","year":"2010","journal-title":"Interdiscipl. Toxicol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.pneurobio.2011.04.010","article-title":"The emergence of designed multiple ligands for neurodegenerative disorders","volume":"94","author":"Geldenhuys","year":"2011","journal-title":"Progr. Neurobiol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.ajhg.2010.03.002","article-title":"Severe X-linked mitochondrial encephalomyopathy associated with a mutation in apoptosis-inducing factor","volume":"86","author":"Ghezzi","year":"2010","journal-title":"Am. J. Hum. Genet."},{"key":"B84","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1097\/JCP.0b013e31820469ea","article-title":"Advances pertaining to the pharmacology and interactions of irreversible nonselective monoamine oxidase inhibitors","volume":"31","author":"Gillman","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1255555","DOI":"10.1126\/science.1255555","article-title":"NEURODEGENERATION. Alzheimer's and Parkinson's diseases: the prion concept in relation to assembled A beta, tau, and alpha-synuclein","volume":"349","author":"Goedert","year":"2015","journal-title":"Science"},{"key":"B86","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1063\/1.1416902","article-title":"Thermodinamic quantities for the ionization reactions of buffers","volume":"31","author":"Goldberg","year":"2002","journal-title":"J. Phys. Chem. Ref. Data"},{"key":"B87","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1017\/S1041610203008676","article-title":"Butyrylcholinesterase: an important new target in Alzheimer's disease therapy","volume":"14","author":"Greig","year":"2002","journal-title":"Int. Psychogeriatr."},{"key":"B88","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1083\/jcb.200704112","article-title":"Regulation of the mitochondrial dynamin-like protein Opa1 by proteolytic cleavage","volume":"178","author":"Griparic","year":"2007","journal-title":"J. Cell Biol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"18792","DOI":"10.1074\/jbc.M400920200","article-title":"Loss of the intermembrane space protein Mgm1\/OPA1 induces swelling and localized constrictions along the lengths of mitochondria","volume":"279","author":"Griparic","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B90","doi-asserted-by":"publisher","first-page":"373","DOI":"10.2174\/0929867321666141106122628","article-title":"Recent Development of multifunctional agents as potential drug candidates for the treatment of Alzheimer's Disease","volume":"22","author":"Guzior","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"B91","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.1016\/j.febslet.2015.10.021","article-title":"Understanding the susceptibility of dopamine neurons to mitochondrial stressors in Parkinson's disease","volume":"589","author":"Haddad","year":"2015","journal-title":"FEBS Lett."},{"key":"B92","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.mito.2004.05.007","article-title":"The machinery of mitochondrial fusion, division, and distribution, and emerging connections to apoptosis","volume":"4","author":"Hales","year":"2004","journal-title":"Mitochondrion"},{"key":"B93","first-page":"12","article-title":"Mitochondrial fusion and division","volume":"3","author":"Hales","year":"2010","journal-title":"Nat. Educ."},{"key":"B94","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/FPC.0b013e3282f5106e","article-title":"Genetic predisposition to Parkinson's disease: CYP2D6 and HFE in the Faroe Islands","volume":"18","author":"Halling","year":"2008","journal-title":"Pharmacogenet. Genomics"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.molcel.2015.04.020","article-title":"Interaction between AIF and CHCHD4 regulates respiratory chain biogenesis","volume":"58","author":"Hangen","year":"2015","journal-title":"Mol. Cell"},{"key":"B96","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ejphar.2015.10.037","article-title":"Effects of harmine, an acetylcholinesterase inhibitor, on spatial learning and memory of APP\/PS1 transgenic mice and scopolamine-induced memory impairment mice","volume":"768","author":"He","year":"2015","journal-title":"Eur. J. Pharmac."},{"key":"B97","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/molecules21040410","article-title":"Synthesis, molecular modelling and biological evaluation of novel Heterodimeric, multiple ligands targeting Cholinesterases and Amyloid Beta","volume":"21","author":"Hebda","year":"2016","journal-title":"Molecules."},{"key":"B98","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0076-6879(94)34129-X","article-title":"Antioxidant action of stobadine","volume":"234","author":"Hor\u00e1kov\u00e1","year":"1994","journal-title":"Meth. Enzymol."},{"key":"B99","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0306-3623(97)00300-5","article-title":"Antioxidant and pharmacodynamic effects of pyridoindole stobadine","volume":"30","author":"Hor\u00e1kov\u00e1","year":"1998","journal-title":"Gen. Pharmacol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/cns.12161","article-title":"A new motif in the N-terminal of acetylcholinesterase triggers amyloid-\u03b2 aggregation and deposition","volume":"20","author":"Hou","year":"2014","journal-title":"CNS. Neurosci. Ther."},{"key":"B101","doi-asserted-by":"publisher","first-page":"730","DOI":"10.2174\/0929867322666141212120631","article-title":"Benzothiazoles - Scaffold of Interest for CNS Targeted Drugs","volume":"22","author":"Hroch","year":"2015","journal-title":"Curr. Med. Chem."},{"issue":"177","key":"B102","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2016.00177","article-title":"One for all? Hitting multiple Alzheimer's disease targets with one drug","volume":"10","author":"Hughes","year":"2016","journal-title":"Front. Neurosci."},{"key":"B103","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S0896-6273(00)80108-7","article-title":"Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme","volume":"16","author":"Inestrosa","year":"1996","journal-title":"Neuron"},{"key":"B104","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/j.1742-4658.2007.06238.x","article-title":"Amyloid-cholinesterase interactions - Implications for Alzheimer's disease","volume":"275","author":"Inestrosa","year":"2008","journal-title":"FEBS J."},{"key":"B105","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00210-003-0819-z","article-title":"Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms","volume":"369","author":"Ingelman-Sundberg","year":"2004","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"625","DOI":"10.2217\/pgs.10.59","article-title":"The past, present and future of pharmacoepigenomics","volume":"11","author":"Ingelman-Sundberg","year":"2010","journal-title":"Pharmacogenomics"},{"key":"B107","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.1038\/sj.emboj.7601184","article-title":"Regulation of mitochondrial morphology through proteolytic cleavage of OPA1","volume":"25","author":"Ishihara","year":"2006","journal-title":"EMBO J."},{"key":"B108","doi-asserted-by":"publisher","first-page":"4938","DOI":"10.1523\/JNEUROSCI.0229-08.2008","article-title":"Loss of apoptosis-inducing factor results in cell-type-specific neurogenesis defects","volume":"28","author":"Ishimura","year":"2008","journal-title":"J. Neurosci."},{"key":"B109","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1124\/jpet.112.192138","article-title":"Mitochondrial dysfunction in neurodegenerative diseases","volume":"342","author":"Johri","year":"2012","journal-title":"J. Pharamacol. Exp. Ther."},{"key":"B110","doi-asserted-by":"publisher","first-page":"10261","DOI":"10.1128\/MCB.25.23.10261-10272.2005","article-title":"Muscle-specific loss of apoptosis-inducing factor leads to mitochondrial dysfunction, skeletal muscle atrophy, and dilated cardiomyopathy","volume":"25","author":"Joza","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbapap.2013.11.003","article-title":"Exploring the structural basis of the selective inhibition of monoamine oxidase A by dicarbonitrile aminoheterocycles: role of Asn181 and Ile335 validated by spectroscopic and computational studies","volume":"1844","author":"Ju\u00e1rez-Jim\u00e9nez","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"B112","doi-asserted-by":"publisher","first-page":"552","DOI":"10.2174\/092986710790416317","article-title":"Antioxidants in treating pathologies involving oxidative damage: an update on medicinal chemistry and biological activity of stobadine and related pyridoindoles","volume":"17","author":"Juranek","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"B113","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.bbamcr.2010.09.010","article-title":"Monoamine oxidases (MAO). in the pathogenesis of heart failure and ischemia\/reperfusion injury","volume":"1813","author":"Kaludercic","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"B114","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1146\/annurev-pharmtox-032112-135923","article-title":"Structure-function of the G protein-coupled receptor superfamily","volume":"53","author":"Katritch","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"B115","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00702-003-0828-6","article-title":"Early and persistent alterations in prefrontal cortex MAO A and B in Alzheimer's disease","volume":"110","author":"Kennedy","year":"2003","journal-title":"J. Neural. Transm."},{"key":"B116","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.mito.2015.01.001","article-title":"From ventriculomegaly to severe muscular atrophy: expansion of the clinical spectrum related to mutations in AIFM1","volume":"21C","author":"Kettwig","year":"2015","journal-title":"Mitochondrion"},{"key":"B117","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1006\/abbi.1996.9771","article-title":"Inhibition of monoamine oxidase A by beta-carboline derivatives","volume":"337","author":"Kim","year":"1997","journal-title":"Arch. Biochem. Biophys."},{"key":"B118","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1016\/S0021-9258(18)50153-8","article-title":"Esters of methanesulfonic acid as irreversible inhibitors of acetylcholinesterase","volume":"237","author":"Kitz","year":"1962","journal-title":"J. Biol. Chem."},{"key":"B119","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nature01034","article-title":"The harlequin mouse mutation downregulates apoptosis-inducing factor","volume":"419","author":"Klein","year":"2002","journal-title":"Nature"},{"key":"B120","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1038\/ncomms4041","article-title":"Mia40 targets cysteines in a hydrophobic environment to direct oxidative protein folding in the mitochondria","volume":"5","author":"Koch","year":"2014","journal-title":"Nat. Commun."},{"key":"B121","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1126\/science.1099793","article-title":"Structural basis of mitochondrial tethering by mitofusin complexes","volume":"305","author":"Koshiba","year":"2004","journal-title":"Science"},{"key":"B122","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1006\/bbrc.1995.1079","article-title":"Dramatic species differences in the susceptibility of Monoamine-Oxidase-B to a group of powerful inhibitors","volume":"206","author":"Krueger","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B123","doi-asserted-by":"publisher","first-page":"667","DOI":"10.3233\/JAD-150393","article-title":"Histamine H3 Receptor Antagonists for Alzheimer's Disease: a systematic review and meta-analysis of Randomized Placebo-controlled trials","volume":"48","author":"Kubo","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"B124","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1089\/ars.2011.4279","article-title":"The novel multi-target iron chelating-radical scavenging compound M30 possesses beneficial effects on major hallmarks of Alzheimer's disease","volume":"17","author":"Kupershmidt","year":"2012","journal-title":"Antiox. Redox Signal."},{"key":"B125","doi-asserted-by":"publisher","first-page":"E3825","DOI":"10.1073\/pnas.1410315111","article-title":"Design of donecopride, a dual serotonin subtype 4 receptor agonist\/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment","volume":"111","author":"Lecoutey","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B126","doi-asserted-by":"publisher","first-page":"5001","DOI":"10.1091\/mbc.E04-04-0294","article-title":"Roles of the mammalian mitochondrial fission and fusion mediators Fis1, Drp1, and Opa1 in apoptosis","volume":"15","author":"Lee","year":"2004","journal-title":"Mol. Biol. Cell"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1172\/JCI118492","article-title":"Specific genetic deficiencies of the A and B isoenzymes of monoamine oxidase are characterized by distinct neurochemical and clinical phenotypes","volume":"97","author":"Lenders","year":"1996","journal-title":"J. Clin. Invest."},{"key":"B128","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/med.20248","article-title":"Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease","volume":"33","author":"Le\u00f3n","year":"2013","journal-title":"Med. Res. Rev."},{"key":"B129","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/978-94-007-2869-1_12","article-title":"Mitochondria in neurodegeneration","volume":"942","author":"Lezi","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.expneurol.2007.02.001","article-title":"5-HT4 receptor and Alzheimer's disease: the amyloid connection","volume":"205","author":"Lezoualc'h","year":"2007","journal-title":"Exp. Neurol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.neuroscience.2015.10.020","article-title":"Inhibition of Drp1 by Mdivi-1 attenuates cerebral ischemic injury via inhibition of the mitochondria-dependent apoptotic pathway after cardiac arrest","volume":"311","author":"Li","year":"2015","journal-title":"Neuroscience"},{"key":"B132","doi-asserted-by":"publisher","first-page":"12","DOI":"10.5144\/0256-4947.2014.12","article-title":"The relationship between monoamine oxidase B (MAOB). A644G polymorphism and Parkinson disease risk: a meta-analysis","volume":"34","author":"Liu","year":"2014","journal-title":"Ann. Saudi Med."},{"key":"B133","doi-asserted-by":"publisher","first-page":"e84413","DOI":"10.1371\/journal.pone.0084413","article-title":"CYP2D6*4 allele polymorphism increases the risk of Parkinson's disease: evidence from meta-analysis","volume":"8","author":"Lu","year":"2013","journal-title":"PLoS ONE"},{"key":"B134","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3565(24)34860-8","article-title":"Activation of human cytochrome P-450 3A4-catalyzed meloxicam 5\u2032-methylhydroxylation by quinidine and hydroquinidine in vitro","volume":"290","author":"Ludwig","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B135","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1017\/S1092852912000594","article-title":"Opportunities for reversible inhibitors of monoamine oxidase-A (RIMAs). in the treatment of depression","volume":"17","author":"Lum","year":"2012","journal-title":"CNS Spectr."},{"key":"B136","doi-asserted-by":"publisher","first-page":"9089","DOI":"10.1021\/jm401047q","article-title":"Synthesis and evaluation of multi-target-directed ligands against Alzheimer's Disease based on the fusion of Donepezil and Ebselen","volume":"56","author":"Luo","year":"2013","journal-title":"J. Med. Chem."},{"key":"B137","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1126\/science.1091230","article-title":"ABAD directly links A beta to mitochondrial toxicity in Alzheimer's disease","volume":"304","author":"Lustbader","year":"2004","journal-title":"Science"},{"key":"B138","first-page":"504","article-title":"The use DRAGON molecular descriptors for the estimation of pharmacologic profile of dibenzothiepine and pyridoindole compounds","volume-title":"Pokroky v analytickej ch\u00e9mii","author":"Majekova","year":"2013"},{"key":"B139","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1111\/febs.13260","article-title":"cis-cyclopropylamines as mechanism-based inhibitors of monoamine oxidases","volume":"282","author":"Malcomson","year":"2015","journal-title":"FEBS. J."},{"key":"B140","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1242\/jcs.03443","article-title":"A cell biological perspective on mitochondrial dysfunction in Parkinson disease and other neurodegenerative diseases","volume":"120","author":"Mandemakers","year":"2007","journal-title":"J. Cell. Sci."},{"issue":"294","key":"B141","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2016.00294","article-title":"ASS234, as a new multi-target directed Propargylamine for Alzheimer's Disease therapy","volume":"10","author":"Marco-Contelles","year":"2016","journal-title":"Front. Neurosci."},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1002\/9780470015902.a0000601.pub2","author":"McDonald","year":"2012","journal-title":"Enzymes: Irreversible Inhibition."},{"key":"B143","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.phrs.2010.09.001","article-title":"On the formation and nature of the imidazoline I(2). binding site on human monoamine oxidase-B","volume":"62","author":"McDonald","year":"2010","journal-title":"Pharmacol. Res."},{"key":"B144","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1002\/jmri.21731","article-title":"MRI and histological analysis of beta-amyloid plaques in both human Alzheimer's disease and APP\/PS1 transgenic mice","volume":"29","author":"Meadowcroft","year":"2009","journal-title":"J. Magn. Reson. Imaging"},{"key":"B145","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.drudis.2013.09.005","article-title":"Allosteric modulation of the M1 muscarinic acetylcholine receptor: improving cognition and a potential treatment for schizophrenia and Alzheimer's disease","volume":"18","author":"Melancon","year":"2013","journal-title":"Drug Discov. Today"},{"key":"B146","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S0306-4522(01)00613-3","article-title":"Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine","volume":"110","author":"Mesulam","year":"2002","journal-title":"Neuroscience"},{"key":"B147","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1001\/archpsyc.63.11.1209","article-title":"Elevated monoamine oxidase A levels in the brain - An explanation for the monoamine imbalance of major depression","volume":"63","author":"Meyer","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"B148","doi-asserted-by":"publisher","first-page":"e1814","DOI":"10.1038\/cddis.2015.170","article-title":"Loss of apoptosis-inducing factor critically affects MIA40 function","volume":"6","author":"Meyer","year":"2015","journal-title":"Cell. Death. Dis."},{"key":"B149","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11010-012-1281-3","article-title":"Antioxidant SMe1EC2 may attenuate the disbalance of sodium homeostasis in the organism induced by higher intake of cholesterol","volume":"366","author":"M\u00e9ze\u0161ov\u00e1","year":"2012","journal-title":"Mol. Cell. Biochem."},{"key":"B150","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/npp.2008.110","article-title":"Brain drug-metabolizing cytochrome P450 enzymes are active in vivo, demonstrated by mechanism-based enzyme inhibition","volume":"34","author":"Miksys","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"B151","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1503\/jpn.120133","article-title":"Cytochrome P450-mediated drug metabolism in the brain","volume":"38","author":"Miksys","year":"2013","journal-title":"J. Psychiatry Neurosci."},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.2210\/pdb3zyx\/pdb","author":"Milczek","year":"2011","journal-title":"3zyx: Crystal Structure of Human Monoamine Oxidase b in Complex with Methylene Blue and Bearing the Double Mutation i199a-y326a. Protein Data Bank."},{"key":"B153","doi-asserted-by":"publisher","first-page":"16391","DOI":"10.1074\/jbc.M010498200","article-title":"NADH oxidase activity of mitochondrial apoptosis-inducing factor","volume":"276","author":"Miramar","year":"2001","journal-title":"J. Biol. Chem."},{"key":"B154","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.bbadis.2009.10.006","article-title":"Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology","volume":"1802","author":"Moreira","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"B155","doi-asserted-by":"publisher","first-page":"R1082","DOI":"10.1152\/ajpregu.00449.2010","article-title":"Neurodegeneration in an animal model of Parkinson's disease is exacerbated by a high-fat diet","volume":"299","author":"Morris","year":"2010","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Phys."},{"key":"B156","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0005-2744(69)90420-3","article-title":"Kinetics of reversible inhibition of enzyme-catalysed reactions by tight-binding inhibitors","volume":"185","author":"Morrison","year":"1969","journal-title":"Biochim. Biophys. Acta"},{"key":"B157","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1750-1326-9-43","article-title":"Alpha-synuclein and tau: teammates in neurodegeneration?","volume":"9","author":"Moussaud","year":"2014","journal-title":"Mol. Neurodegener."},{"key":"B158","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20081386","article-title":"How mitochondria produce reactive oxygen species","volume":"417","author":"Murphy","year":"2009","journal-title":"Biochem. J."},{"key":"B159","doi-asserted-by":"publisher","first-page":"20710","DOI":"10.1074\/jbc.M110.213538","article-title":"Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein alpha-synuclein","volume":"286","author":"Nakamura","year":"2011","journal-title":"J. Biol. Chem."},{"key":"B160","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.2174\/138161210793176527","article-title":"Monoamine Oxidase inhibitors as neuroprotective agents in age-dependent neurodegenerative disorders","volume":"16","author":"Naoi","year":"2010","journal-title":"Curr. Pharm. Design."},{"key":"B161","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/978-3-211-33328-0_8","article-title":"Involvement of type A monoamine oxidase in neurodegeneration: regulation of mitochondrial signaling leading to cell death or neuroprotection","volume":"71","author":"Naoi","year":"2006","journal-title":"J. Neural Transm. Suppl."},{"key":"B162","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/978-3-211-73574-9_15","article-title":"Neuroprotection by propargylamines in Parkinson's disease: intracellular mechanism underlying the anti-apoptotic function and search for clinical markers","volume":"72","author":"Naoi","year":"2007","journal-title":"J. Neural Transm. Suppl."},{"key":"B163","doi-asserted-by":"publisher","first-page":"20120431","DOI":"10.1098\/rstb.2012.0431","article-title":"Human cytochromes P450 in health and disease","volume":"368","author":"Nebert","year":"2013","journal-title":"Philos. Trans. R. Soc. Lond. Biol. Sci."},{"key":"B164","doi-asserted-by":"publisher","first-page":"41141","DOI":"10.1074\/jbc.M210241200","article-title":"Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products","volume":"278","author":"Nicolet","year":"2003","journal-title":"J. Biol. Chem."},{"key":"B165","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s10822-014-9816-1","article-title":"Predicting targets of compounds against neurological diseases using cheminformatic methodology","volume":"29","author":"Nikolic","year":"2015","journal-title":"J. Comput. Aided Mol. Des."},{"issue":"265","key":"B166","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2016.00265","article-title":"Drug design for CNS diseases: polypharmacological profiling of compounds using cheminformatic, 3D-QSAR and virtual screening methodologies","volume":"10","author":"Nikolic","year":"2016","journal-title":"Front. Neurosci"},{"key":"B167","doi-asserted-by":"publisher","first-page":"6264","DOI":"10.1021\/jm060441e","article-title":"Impact of species-dependent differences on screening, design, and development of MAO B inhibitors","volume":"49","author":"Novaroli","year":"2006","journal-title":"J. Med. Chem."},{"key":"B168","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.cell.2012.02.035","article-title":"Mitochondria: in sickness and in health","volume":"148","author":"Nunnari","year":"2012","journal-title":"Cell"},{"key":"B169","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.bbrc.2005.08.092","article-title":"Phosphorylation of cytochromes P450: first discovery of a posttranslational modification of a drug-metabolizing enzyme","volume":"338","author":"Oesch-Bartlomowicz","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B170","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev.neuro.22.1.123","article-title":"Ethiology and pathogenesis of Parkinson's disease","volume":"22","author":"Olanow","year":"1999","journal-title":"Ann. Rev. Neurosci."},{"key":"B171","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1007\/s12035-014-8974-4","article-title":"Inhibition of excessive monoamine oxidase A\/B activity protects against stress-induced neuronal death in Huntington Disease","volume":"52","author":"Ooi","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"B172","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1124\/dmd.109.027680","article-title":"MicroRNAs regulate CYP3A4 expression via direct and indirect targeting","volume":"37","author":"Pan","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"B173","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1016\/j.bmc.2013.02.017","article-title":"A comprehensive review on synthesis and designing aspects of coumarin derivatives as monoamine oxidase inhibitors for depression and Alzheimer's disease","volume":"21","author":"Patil","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"B174","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1212\/WNL.56.10.1363","article-title":"Parkinson's disease, CYP2D6 polymorphism, and age","volume":"56","author":"Payami","year":"2001","journal-title":"Neurology"},{"key":"B175","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/ana.22034","article-title":"Apoptosis-inducing factor deficiency sensitizes dopaminergic neurons to parkinsonian neurotoxins","volume":"68","author":"Perier","year":"2010","journal-title":"Ann. Neurol."},{"key":"B176","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1089\/ars.2011.4074","article-title":"Mitochondria and programmed cell death in Parkinson's disease: apoptosis and beyond","volume":"16","author":"Perier","year":"2012","journal-title":"Antiox. Redox Signal."},{"key":"B177","doi-asserted-by":"publisher","first-page":"a009332","DOI":"10.1101\/cshperspect.a009332","article-title":"Mitochondrial biology and Parkinson's disease","volume":"2","author":"Perier","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B178","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1159\/000072926","article-title":"Parkinson's disease and CYP2D6 polymorphism in Asian populations: a meta-analysis","volume":"22","author":"Persad","year":"2003","journal-title":"Neuroepidemiology"},{"key":"B179","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/0014-5793(96)00988-X","article-title":"Mitochondria and programmed cell death: back to the future","volume":"396","author":"Petit","year":"1996","journal-title":"FEBS Lett."},{"key":"B180","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.bmcl.2007.09.100","article-title":"Multi-target-directed coumarin derivatives: hAChE and BACE1 inhibitors as potential anti-Alzheimer compounds","volume":"18","author":"Piazzi","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B181","doi-asserted-by":"publisher","first-page":"4568","DOI":"10.2174\/092986711797379302","article-title":"Targeting monoamine oxidases with multipotent ligands: an emerging strategy in the search of new drugs against neurodegenerative diseases","volume":"18","author":"Pisani","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"B182","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3390\/molecules21030362","article-title":"Searching for multi-targeting neurotherapeutics against Alzheimer's: discovery of potent AChE-MAO B inhibitors through the decoration of the 2H-Chromen-2-one structural motif","volume":"21","author":"Pisani","year":"2016","journal-title":"Molecules"},{"key":"B183","doi-asserted-by":"publisher","first-page":"e82562","DOI":"10.1371\/journal.pone.0082562","article-title":"Polymorphic cytochrome P450 enzymes (CYPs) and their role in personalized therapy","volume":"8","author":"Preissner","year":"2013","journal-title":"PLoS ONE"},{"key":"B184","doi-asserted-by":"publisher","first-page":"711","DOI":"10.2174\/157340611797928370","article-title":"Novel hexahydropyridoindole derivative as prospective agent against oxidative damage in pancreatic \u03b2 cells","volume":"7","author":"Ra\u010dkov\u00e1","year":"2011","journal-title":"Med. Chem."},{"key":"B185","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1080\/10715760903104374","article-title":"Metabolism-induced oxidative stress is a mediator of glucose toxicity in HT22 neuronal cells","volume":"43","author":"Rackova","year":"2009","journal-title":"Free. Radic. Res."},{"key":"B186","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1021\/jm060041r","article-title":"Free radical scavenging and antioxidant activities of substituted hexahydropyridoindoles. Quantitative structure-activity relationships","volume":"49","author":"Rackova","year":"2006","journal-title":"J. Med. Chem."},{"key":"B187","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/sj.bjp.0707430","article-title":"Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A). confirms a theoretical prediction","volume":"152","author":"Ramsay","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"B188","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s00702-011-0657-y","article-title":"An improved approach to steady-state analysis of monoamine oxidases","volume":"118","author":"Ramsay","year":"2011","journal-title":"J. Neural Transm."},{"key":"B189","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/j.bbadis.2013.09.003","article-title":"Mitochondrial permeability transition pore is a potential drug target for neurodegeneration","volume":"1842","author":"Rao","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"B190","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1006\/bbrc.1997.6357","article-title":"A monoclonal antibody against acetylcholinesterase inhibits the formation of amyloid fibrils induced by the enzyme","volume":"232","author":"Reyes","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B191","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/0003-2697(79)90792-9","article-title":"Ellman's reagent: 5,5\u2032-dithiobis(2-nitrobenzoic acid).-reexamination","volume":"94","author":"Riddles","year":"1979","journal-title":"Anal. Biochem."},{"key":"B192","first-page":"271","article-title":"P450 and heme oxygenase enzymes in the basal ganglia and their roles in Parkinson's disease","volume":"80","author":"Riedl","year":"1999","journal-title":"Adv. Neurol."},{"key":"B193","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.ajhg.2012.10.008","article-title":"Cowchock syndrome is associated with a mutation in apoptosis-inducing factor","volume":"91","author":"Rinaldi","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"B194","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.bbadis.2009.09.005","article-title":"Mitochondrial trafficking and morphology in neuronal injury","volume":"1802","author":"Rintoul","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"B195","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1021\/acs.jmedchem.5b00115","article-title":"Novel multitarget-directed ligands (MTDLs) with acetylcholinesterase (AChE) inhibitory and serotonergic subtype 4 receptor (5-HT4R) agonist activities as potential agents against Alzheimer's disease: the design of donecopride","volume":"58","author":"Rochais","year":"2015","journal-title":"J. Med. Chem."},{"key":"B196","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1021\/jm801327q","article-title":"Design, synthesis, and biological evaluation of New 5-HT(4). receptor agonists: application as amyloid cascade modulators and potential therapeutic utility in Alzheimer's Disease","volume":"52","author":"Russo","year":"2009","journal-title":"J. Med. Chem."},{"key":"B197","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1503\/jpn.100117","article-title":"Monoamine oxidase A inhibitor occupancy during treatment of major depressive episodes with moclobemide or St. John's wort: an [C-11]-harmine PET study","volume":"36","author":"Sacher","year":"2011","journal-title":"J. Psychiatry Neurosci."},{"key":"B198","doi-asserted-by":"publisher","first-page":"4665","DOI":"10.1016\/j.ejmech.2011.05.048","article-title":"Synthesis, biological assessment and molecular modeling of new multipotent MAO and cholinesterase inhibitors as potential drugs for the treatment of Alzheimer's disease","volume":"46","author":"Samadi","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"B199","volume-title":"Derivatives of Propargylamine having Neuroprotective Capacity for the Treatment of Alzheimer's and Parkinson's Diseases","author":"Samadi","year":"2015"},{"issue":"28","key":"B200","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2015.00028","article-title":"Systemic inflammation and the brain: novel roles of genetic, molecular, and environmental cues as drivers of neurodegeneration","volume":"9","author":"Sankowski","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"B201","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1021\/jm0509849","article-title":"A QSAR model for in silico screening of MAO-A inhibitors. Prediction, synthesis, and biological assay of novel coumarins","volume":"49","author":"Santana","year":"2006","journal-title":"J. Med. Chem."},{"key":"B202","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/S0008-6363(99)00384-3","article-title":"Morphologic and biochemical hallmarks of apoptosis","volume":"45","author":"Saraste","year":"2000","journal-title":"Cardiovasc. Res."},{"key":"B203","doi-asserted-by":"publisher","first-page":"159160","DOI":"10.4061\/2011\/159160","article-title":"Mitochondrial contribution to Parkinson's disease pathogenesis","volume":"2011","author":"Schapira","year":"2011","journal-title":"Parkinsons Dis."},{"key":"B204","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.bbadis.2011.06.016","article-title":"Neurodegeneration with brain iron accumulation Clinical syndromes and neuroimaging","volume":"1822","author":"Schipper","year":"2012","journal-title":"Biochim Biophys. Acta"},{"key":"B205","doi-asserted-by":"publisher","first-page":"4408","DOI":"10.1021\/bi0618621","article-title":"trans-2-phenylcyclopropylamine is a mechanism-based inactivator of the histone demethylase LSD1","volume":"46","author":"Schmidt","year":"2007","journal-title":"Biochemistry"},{"key":"B206","doi-asserted-by":"publisher","first-page":"211","DOI":"10.2478\/v10102-011-0032-8","article-title":"Anxiolytic activity of pyridoindole derivatives SMe1EC2 and SMe1M2: behavioral analysis using rat model","volume":"4","author":"Sedl\u00e1\u010dkov\u00e1","year":"2011","journal-title":"Interdiscip. Toxicol."},{"key":"B207","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.jmb.2009.05.013","article-title":"Redox-linked conformational dynamics in apoptosis-inducing factor","volume":"390","author":"Sevrioukova","year":"2009","journal-title":"J. Mol. Biol."},{"key":"B208","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1089\/ars.2010.3445","article-title":"Apoptosis-inducing factor: structure, function, and redox regulation","volume":"14","author":"Sevrioukova","year":"2011","journal-title":"Antioxid. Redox Signal."},{"key":"B209","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/syn.20505","article-title":"Cytochrome P450 2E1 in the substantia nigra: relevance for dopaminergic neurotransmission and free radical production","volume":"62","author":"Shahabi","year":"2008","journal-title":"Synapse"},{"key":"B210","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0090-9556(25)07388-X","article-title":"Inactivation of cytochrome P4502B1 by the monoamine oxidase inhibitors R-(-).-deprenyl and clorgyline","volume":"24","author":"Sharma","year":"1996","journal-title":"Drug Metab. Dispos."},{"key":"B211","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1016\/j.bmcl.2011.02.072","article-title":"Exploration of new scaffolds as potential MAO-A inhibitors using pharmacophore and 3D-QSAR based in silico screening","volume":"21","author":"Shelke","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B212","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1083\/jcb.201312123","article-title":"Mitochondrial trafficking and anchoring in neurons: New insight and implications","volume":"204","author":"Sheng","year":"2014","journal-title":"J. Cell Biol."},{"key":"B213","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nrn3156","article-title":"Mitochondrial transport in neurons: impact on synaptic homeostasis and neurodegeneration","volume":"13","author":"Sheng","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"B214","first-page":"235","article-title":"MAO-A and -B gene knock-out mice exhibit distinctly different behavior","volume":"7","author":"Shih","year":"1999","journal-title":"Neurobiology (Bp)."},{"key":"B215","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1016\/S0021-9258(17)43725-2","article-title":"Mechanism of inactivation of monoamine-oxidase by trans-2-phenylcyclopropylamine and the structure of the enzyme-inactivator adduct","volume":"258","author":"Silverman","year":"1983","journal-title":"J. Biol. Chem."},{"key":"B216","author":"Simone","year":"2014","journal-title":"Interaction of Novel Monoamino Oxidase Inhibitor with Cytochrome P450, Xjenza online, 94."},{"key":"B217","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1177\/0891988714522698","article-title":"Polymorphism in cytochrome P450 2D6, Glutathione S-Transferases Pi 1 genes, and organochlorine pesticides in Alzheimer Disease: a case-control study in North Indian Population","volume":"27","author":"Singh","year":"2014","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"B218","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1021\/tx400021f","article-title":"Profiling 976 ToxCast chemicals across 331 enzymatic and receptor signaling assays","volume":"26","author":"Sipes","year":"2013","journal-title":"Chem. Res. Toxicol."},{"key":"B219","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.2174\/1389200214666131211153307","article-title":"Post-translational and post-transcriptional modifications of pregnane X receptor (PXR) in regulation of the cytochrome P450 superfamily","volume":"14","author":"Smutny","year":"2013","journal-title":"Curr. Drug Metab."},{"key":"B220","doi-asserted-by":"publisher","first-page":"6996","DOI":"10.1021\/acs.biochem.5b00898","article-title":"Key role of the adenylate moiety and integrity of the Adenylate-Binding Site for the NAD(+)\/H Binding to mitochondrial apoptosis-inducing factor","volume":"54","author":"Sorrentino","year":"2015","journal-title":"Biochemistry"},{"key":"B221","doi-asserted-by":"publisher","first-page":"20","DOI":"10.2478\/v10102-011-0005-y","article-title":"Protection of the vascular endothelium in experimental situations","volume":"4","author":"Sotn\u00edkov\u00e1","year":"2011","journal-title":"Interdiscip. Toxicol."},{"key":"B222","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1124\/dmd.112.046979","article-title":"Inhibition of bupropion metabolism by selegiline: mechanism-based inactivation of human CYP2B6 and characterization of glutathione and peptide adducts","volume":"40","author":"Sridar","year":"2012","journal-title":"Drug Metab. Dispos."},{"key":"B223","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1179\/1351000213Y.0000000043","article-title":"Antioxidant action of the hexahydropyridoindole SMe1EC2 in the cellular system of isolated red blood cells in vitro","volume":"18","author":"Stefek","year":"2013","journal-title":"Redox Rep."},{"key":"B224","volume-title":"Pyridoindole Derivatives with Antioxidant Properties: Synthesis, Therapy and Pharmaceutical Remedies.","author":"Stolc","year":"2010"},{"key":"B225","first-page":"316","article-title":"Pyridoindoles with antioxidant and neuroprotective actions: a review","volume-title":"New frontiers in Molecular Mechanisms in Neurological and Psychiatric Disorders","author":"Stolc","year":"2011"},{"key":"B226","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1007\/s10571-006-9037-9","article-title":"Development of the new group of indole-derived neuroprotective drugs affecting oxidative stress","volume":"26","author":"Stolc","year":"2006","journal-title":"Cell. Mol. Neurobiol."},{"key":"B227","doi-asserted-by":"publisher","first-page":"3621","DOI":"10.1007\/s00216-014-7793-9","article-title":"Metabolism of JWH-015, JWH-098, JWH-251, and JWH-307 in silico and in vitro: a pilot study for the detection of unknown synthetic cannabinoids metabolites","volume":"406","author":"Strano-Rossi","year":"2014","journal-title":"Anal. Bioanal. Chem."},{"key":"B228","doi-asserted-by":"publisher","first-page":"4784","DOI":"10.1016\/j.bmc.2014.06.057","article-title":"Syntheses of coumarin-tacrine hybrids as dual-site acetylcholinesterase inhibitors and their activity against butylcholinesterase, A-beta aggregation, and beta-secretase","volume":"22","author":"Sun","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"B229","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/17135","article-title":"Molecular characterization of mitochondrial apoptosis-inducing factor","volume":"397","author":"Susin","year":"1999","journal-title":"Nature"},{"key":"B230","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1007\/s00204-015-1556-z","article-title":"Oxidative stress in Alzheimer disease and mild cognitive impairment: evidence from human data provided by redox proteomics","volume":"89","author":"Swomley","year":"2015","journal-title":"Arch. Toxicol."},{"key":"B231","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/978-3-7091-9324-2_27","article-title":"Amphetamine-metabolites of deprenyl involved in protection against neurotoxicity induced by MPTP and 2\u2032-methyl-MPTP","volume":"41","author":"Szir\u00e1ki","year":"1994","journal-title":"J. Neural. Transm."},{"key":"B232","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.parkreldis.2008.12.007","article-title":"Pharmacologic treatment of advanced Parkinson's disease: a meta-analysis of COMT inhibitors and MAO-B inhibitors","volume":"15","author":"Talati","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"B233","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nature17188","article-title":"Crystal structures of the M1 and M4 muscarinic acetylcholine receptors","volume":"531","author":"Thal","year":"2016","journal-title":"Nature"},{"key":"B234","doi-asserted-by":"publisher","first-page":"9090","DOI":"10.1158\/0008-5472.CAN-06-1403","article-title":"MicroRNA regulates the expression of human cytochrome P450 1B1","volume":"66","author":"Tsuchiya","year":"2006","journal-title":"Cancer Res."},{"key":"B235","first-page":"639","article-title":"Prenatal developmental toxicity study of the pyridoindole antioxidant SMe1EC2 in rats","volume":"29","author":"Ujhazy","year":"2008","journal-title":"Neuro Endocrinol. Lett."},{"issue":"205","key":"B236","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2016.00205","article-title":"Multi-target directed donepezil-like ligands for Alzheimer's disease","volume":"10","author":"Unzeta","year":"2016","journal-title":"Front. Neurosci."},{"key":"B237","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1021\/bi7019707","article-title":"Comparison of the structural properties of the active site cavities of human and rat monoamine oxidase A and B in their soluble and membrane-bound forms","volume":"47","author":"Upadhyay","year":"2008","journal-title":"Biochemistry"},{"key":"B238","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1038\/sj.emboj.7600746","article-title":"AIF suppresses chemical stress-induced apoptosis and maintains the transformed state of tumor cells","volume":"24","author":"Urbano","year":"2005","journal-title":"EMBO J."},{"key":"B239","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2174\/157015909787602823","article-title":"Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options","volume":"7","author":"Uttara","year":"2009","journal-title":"Curr. Neuropharmacol."},{"issue":"71","key":"B240","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2013.00071","article-title":"Acetaldehyde and parkinsonism: role of CYP450 2E1","volume":"7","author":"Vaglini","year":"2013","journal-title":"Front. Behav. Neurosci."},{"key":"B241","doi-asserted-by":"publisher","first-page":"4679","DOI":"10.1038\/sj.emboj.7600461","article-title":"AIF deficiency compromises oxidative phosphorylation","volume":"23","author":"Vahsen","year":"2004","journal-title":"EMBO J."},{"key":"B242","doi-asserted-by":"publisher","first-page":"128","DOI":"10.2174\/1567205011666140130150108","article-title":"Identification of human ABAD inhibitors for rescuing A-beta-mediated mitochondrial dysfunction","volume":"11","author":"Valaasani","year":"2014","journal-title":"Curr. Alzheimer Res."},{"key":"B243","doi-asserted-by":"publisher","first-page":"e92","DOI":"10.1161\/01.res.0000172081.30327.28","article-title":"Downregulation of apoptosis-inducing factor in harlequin mutant mice sensitizes the myocardium to oxidative stress-related cell death and pressure overload-induced decompensation","volume":"96","author":"van Empel","year":"2005","journal-title":"Circ. Res."},{"key":"B244","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1124\/mol.115.098897","article-title":"A perspective on studying G-Protein-Coupled receptor signaling with resonance energy transfer biosensors in living organisms","volume":"88","author":"van Unen","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"B245","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/j.1468-1331.2006.01590.x","article-title":"Association of A313 G polymorphism (GSTP1*B) in the glutathione-S-transferase P1 gene with sporadic Parkinson's disease","volume":"14","author":"Vilar","year":"2007","journal-title":"Eur. J. Neurol."},{"key":"B246","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.2174\/156802612805219987","article-title":"Predicting monoamine oxidase inhibitory activity through ligand-based models","volume":"12","author":"Vilar","year":"2012","journal-title":"Curr. Top. Med. Chem."},{"key":"B247","doi-asserted-by":"publisher","first-page":"5175","DOI":"10.1021\/acs.biochem.5b00696","article-title":"Key residues regulating the reductase activity of the human mitochondrial apoptosis inducing factor","volume":"54","author":"Villanueva","year":"2015","journal-title":"Biochemistry"},{"issue":"72","key":"B248","doi-asserted-by":"publisher","DOI":"10.3389\/fnsys.2012.00072","article-title":"Histamine H3 receptor antagonists\/inverse agonists on cognitive and motor processes: relevance to Alzheimer's disease, ADHD, schizophrenia, and drug abuse","volume":"6","author":"Vohora","year":"2012","journal-title":"Front. Syst. Neurosci."},{"key":"B249","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1177\/1073858403254006","article-title":"Compartmentation of glutamine, glutamate, and GABA metabolism in neurons and astrocytes: functional implications","volume":"9","author":"Waagepetersen","year":"2003","journal-title":"Neuroscientist"},{"key":"B250","first-page":"1","article-title":"Why enzymes as drug targets?","volume-title":"Evaluation of Enzyme Inhibitors in Drug Discovery: A Guide for Medicinal Chemists and Pharmacologists","author":"Walsh","year":"2013","edition":"2nd Edn"},{"key":"B251","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2741\/s279","article-title":"Histamine receptor subtypes: a century of rational drug design","volume":"1","author":"Walter","year":"2012","journal-title":"Front. Biosci."},{"key":"B252","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1146\/annurev-genet-102108-134850","article-title":"The role of mitochondria in apoptosis*","volume":"43","author":"Wang","year":"2009","journal-title":"Annu. Rev. Genet."},{"key":"B253","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.ejmech.2014.04.078","article-title":"Donepezil + propargylamine + 8-hydroxyquinoline hybrids as new multifunctional metal-chelators, ChE and MAO inhibitors for the potential treatment of Alzheimer's disease","volume":"80","author":"Wang","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"B254","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1750-1326-9-31","article-title":"Dysregulation of protein trafficking in neurodegeneration","volume":"9","author":"Wang","year":"2014","journal-title":"Mol. Neurodegener."},{"key":"B255","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1006\/abbi.1999.1351","article-title":"P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR","volume":"369","author":"Waxman","year":"1999","journal-title":"Arch. Biochem. Biophys."},{"key":"B256","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1016\/j.bmc.2016.04.028","article-title":"Structure-guided development of dual \u03b22 adrenergic\/dopamine D2 receptor agonists","volume":"24","author":"Weichert","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"B257","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2174\/138945012799499794","article-title":"Ladostigil: a novel multimodal neuroprotective drug with cholinesterase and brain-selective monoamine oxidase inhibitory activities for Alzheimer's disease treatment","volume":"13","author":"Weinreb","year":"2012","journal-title":"Curr. Drug Targets"},{"key":"B258","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1111\/bph.13318","article-title":"Neuroprotective effects of multifaceted hybrid agents targeting MAO, cholinesterase, iron and \u03b2-amyloid in aging and Alzheimer's disease","volume":"173","author":"Weinreb","year":"2016","journal-title":"Br. J. Pharmacol"},{"key":"B259","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/B978-0-12-386467-3.00007-8","article-title":"Neuroprotective profile of the multitarget drug rasagiline in Parkinson's disease","volume":"100","author":"Weinreb","year":"2011","journal-title":"Int. Rev. Neurobiol."},{"key":"B260","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1016\/j.neurobiolaging.2015.05.009","article-title":"Effect of long-term treatment with rasagiline on cognitive deficits and related molecular cascades in aged mice","volume":"36","author":"Weinreb","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"B261","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/S0021-9258(18)69497-9","article-title":"A rapid spectrophotometric assay of Monoamine Oxidase based on the rate of disappearance of kynuramine","volume":"235","author":"Weissbach","year":"1960","journal-title":"J. Biol. Chem"},{"key":"B262","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0022-3565(24)29529-X","article-title":"Transcriptional and post-translational regulation of CYP1A1 by primaquine","volume":"297","author":"Werlinder","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B263","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1016\/j.bbabio.2012.02.033","article-title":"Bioenergetic role of mitochondrial fusion and fission","volume":"1817","author":"Westermann","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"B264","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.tins.2015.08.002","article-title":"Priming the Inflammatory Pump of the CNS after Traumatic Brain Injury","volume":"38","author":"Witcher","year":"2015","journal-title":"Trends Neurosci."},{"key":"B265","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.molmed.2013.11.007","article-title":"Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis","volume":"20","author":"Witte","year":"2014","journal-title":"Trends Mol. Med."},{"key":"B266","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.celrep.2014.10.023","article-title":"iPSC-derived dopamine neurons reveal differences between monozygotic twins discordant for Parkinson's disease","volume":"9","author":"Woodard","year":"2014","journal-title":"Cell Reports."},{"key":"B267","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1016\/j.bmc.2016.02.023","article-title":"Design, synthesis and biological evaluation of novel donepezil-coumarin hybrids as multi-target agents for the treatment of Alzheimer's disease","volume":"24","author":"Xie","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"B268","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ejmech.2015.03.040","article-title":"Multi-target tacrine-coumarin hybrids: cholinesterase and monoamine oxidase B inhibition properties against Alzheimer's disease","volume":"95","author":"Xie","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"B269","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.expneurol.2015.08.014","article-title":"Evidence for accelerated tauopathy in the retina of transgenic P301S tau mice exposed to repetitive mild traumatic brain injury","volume":"273","author":"Xu","year":"2015","journal-title":"Exp. Neurol."},{"key":"B270","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.neubiorev.2016.03.025","article-title":"Inhibiting BACE1 to reverse synaptic dysfunctions in Alzheimer's disease","volume":"65","author":"Yan","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B271","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S1474-4422(13)70276-X","article-title":"Targeting the beta secretase BACE1 for Alzheimer's disease therapy","volume":"13","author":"Yan","year":"2014","journal-title":"Lancet Neurol."},{"key":"B272","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.jsbmb.2014.07.001","article-title":"Roles of 17 beta-hydroxysteroid dehydrogenase type 10 in neurodegenerative disorders","volume":"143","author":"Yang","year":"2014","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"B273","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5607\/en.2013.22.1.1","article-title":"Multi target neuroprotective and neurorestorative anti-Parkinson and anti-Alzheimer drugs ladostigil and m30 derived from rasagiline","volume":"22","author":"Youdim","year":"2013","journal-title":"Exp. Neurobiol."},{"key":"B274","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nrn1883","article-title":"The therapeutic potential of monoamine oxidase inhibitors","volume":"7","author":"Youdim","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"B275","doi-asserted-by":"publisher","first-page":"167","DOI":"10.5607\/en.2013.22.3.167","article-title":"Promise of neurorestoration and mitochondrial biogenesis in Parkinson's disease with multi target drugs: an alternative to stem cell therapy","volume":"22","author":"Youdim","year":"2013","journal-title":"Exp. Neurobiol."},{"key":"B276","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1126\/science.1219855","article-title":"Mitochondrial fission, fusion, and stress","volume":"337","author":"Youle","year":"2012","journal-title":"Science"},{"key":"B277","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"B278","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1093\/brain\/awm335","article-title":"OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion","volume":"131","author":"Zanna","year":"2008","journal-title":"Brain"},{"key":"B279","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1016\/j.jprot.2012.01.014","article-title":"Comparative platelet proteome analysis reveals an increase of monoamine oxidase-B protein expression in Alzheimer's disease but not in non-demented Parkinson's disease patients","volume":"75","author":"Zellner","year":"2012","journal-title":"J. Proteomics"},{"key":"B280","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1006\/abio.1997.2391","article-title":"A stable nonfluorescent derivative of resorufin for the fluorometric determination of trace hydrogen peroxide: applications in detecting the activity of phagocyte NADPH oxidase and other oxidases","volume":"253","author":"Zhou","year":"1997","journal-title":"Anal. Biochem."},{"key":"B281","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1016\/j.bmc.2008.12.067","article-title":"Design, synthesis and biological evaluation of novel dual inhibitors of acetylcholinesterase and beta-secretase","volume":"17","author":"Zhu","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"B282","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/ng1341","article-title":"Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A","volume":"36","author":"Z\u00fcchner","year":"2004","journal-title":"Nat. Genet."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T11:17:34Z","timestamp":1749554254000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fnins.2016.00375\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,22]]},"references-count":282,"URL":"https:\/\/doi.org\/10.3389\/fnins.2016.00375","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,22]]}}}